Ligand Pharmaceuticals Director Unloads: Investor Guide
A director sold a chunk of Ligand Pharmaceuticals stock, prompting questions about intent and impact. This guide brea...
Discover how wealth growth through investments and savings can lead to financial independence. Make smart choices for your financial future today.
28,655 articlesA director sold a chunk of Ligand Pharmaceuticals stock, prompting questions about intent and impact. This guide brea...
June markets test XLE as oil dynamics and earnings timing hedges collide. A handful of energy giants drive the ETF, u...
Insilico Medicine and SK Biopharmaceuticals unveiled a milestone collaboration worth up to $2.5 billion to develop ne...
Regulated banks can custody crypto and settle tokenized funds, but Basel's capital rules impose a punishing cost that...
The administration targets a $1.6 trillion tariff-revenue gap with a broader, slower path for tariffs that invites mo...
Amazon delivered strong AWS growth and solid Q1 results, but a large capex plan keeps investors wary. Still, a broad ...
Novo Nordisk signals a major Wegovy price cut set for January 2027, triggering a sharp market reaction as the stock s...
When bitcoin dips under $70k amid a sharp stock sell-off tied to a hawkish FED hold, traders scramble for direction. ...
Planet Labs leads a broad space sector rally, with Rocket Lab and SpaceX climbing alongside space-focused ETFs as inv...
AI-driven capex is lifting lithography demand, placing ASML at the center of a multiyear upgrade cycle. This piece ex...
Qualcomm and Micron lead another leg higher in the AI semiconductor rally, as data center demand and memory tightness...
On this stock market today, june, Rivian jumps as early interest in the R2 SUV grows. We break down what this means f...